Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke can Cause Inferior Myocardial Infarction?

Recombinant tissue plasminogen activator (rTPA) is one of the main portions of acute ischemic stroke management, but unfortunately has some complications. Myocardial infarction (MI) is a hazardous complication of administration of intravenous rTPA that has been reported recently. A 78-year-old lady...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neurol Int
Päätekijät: Almasi, Mostafa, Razmeh, Saeed, Habibi, Amir Hassan, Rezaee, Amir Hassan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: PAGEPress Publications, Pavia, Italy 2016
Aiheet:
Case Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4935817/
https://ncbi.nlm.nih.gov/pubmed/27441068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/ni.2016.6617
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia